Drug intelligence / Profile preview

YFZ-5YH1

Development stage: Unknown
Lead developer: Yifan Pharmaceutical
Administration: Oral

Overview

YFZ-5YH1 is a proprietary traditional Chinese medicine candidate developed by Yifan Pharmaceutical for **cold and flu**. Yifan's public product-pipeline materials identify the program within its traditional Chinese medicine portfolio; the supplied pipeline record reports completion of Phase III trials, while the current Chinese-language pipeline lists the project as under registration review. The constituent ingredients, dosage form, route of administration, and molecular mechanism have not been publicly specified.

Beyond the preview

Go deeper on YFZ-5YH1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on YFZ-5YH1.

Explore the full profile